Skip to main content

Table 2 Results of meta-analysis for TCF4 polymorphisms and risk of FED

From: Association of TCF4 polymorphisms and fuchs’ endothelial dystrophy: a meta-analysis

Polymorphism (comparison)

No. of studies

OR (95%CI)

P

Heterogeneity

P Egger’s testa

P Begg’s testb

x 2

I2

P

rs613872

        

G vs. T

10

4.19(3.53–4.97)

<0.001

16.60

45.8 %

0.055

0.411

0.474

GG vs. GT/TT

6

4.27(2.54–7.19)

<0.001

6.20

19.3 %

0.288

0.295

0.260

GG/GT vs. TT

7

6.29(4.23–8.93)

<0.001

16.23

63.0 %

0.013

0.586

0.707

GG VS. TT

6

10.64(5.28–21.41)

<0.001

9.43

47.0 %

0.093

0.378

0.452

GT VS. TT

6

6.08 (4.28–8.64)

<0.001

12.72

60.7 %

0.026

0.938

0.707

rs2286812

        

T vs C

5

1.77(1.19–2.63)

0.005

12.10

66.9 %

0.017

0.207

0.180

rs17595731

        

C vs G

3

4.70(3.06–7.21)

<0.001

1.27

0.0 %

0.530

0.775

1.000

rs9954153

        

G vs T

3

2.43(1.97–3.01)

<0.001

0.20

0.0 %

0.906

0.793

1.000

  1. TCF4 transcription factor 4; FED Fuchs endothelial dystrophy; OR odds ratio; CI confidence Interval
  2. aP Egger’s test = the P value for Egger’s test
  3. bP Begg’s test = the P value for Begg’s test